CSPC Innovation Pharmaceutical Co., Ltd. (SHE: 300765)

Market Cap	35.44B
Revenue (ttm)	2.04B
Net Income (ttm)	513.13M
Shares Out	1.39B
EPS (ttm)	0.37
PE Ratio	69.06
Forward PE	90.68
Dividend	0.27 (1.00%)
Ex-Dividend Date	n/a

Volume	5,989,736
Open	27.40
Previous Close	26.59
Day's Range	25.29 - 27.40
52-Week Range	19.69 - 37.08
Beta	-0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About CSPC Innovation Pharmaceutical

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, Ch...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 1,887
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2023, CSPC Innovation Pharmaceutical's revenue was 2.50 billion, a decrease of -4.75% compared to the previous year's 2.63 billion. Earnings were 755.56 million, an increase of 4.03%.